DHR · News · 20260902N

End-Market Demand Trends

DANAHER CORP /DE/ · 2026-09-02 · Importance 40 · Surprise 56

The global research-use recombinant protein market is forecast to grow from $1.11 billion in 2026 to $1.55 billion by 2031, representing approximately 40% expansion. Growth is expected to be driven by expanding therapeutic pipelines and increased preclinical research in advanced therapies. Demand is particularly increasing for human-derived proteins, including cytokines and chemokines, while the United States is expected to record the highest compound annual growth rate. Danaher is identified as one of the key market participants alongside Thermo Fisher Scientific, Bio-Techne, Merck KGaA, and Revvity.

Key facts